TC

TDH Capital

North America, Pennsylvania, United States, Radnor

Description

TDH Capital invests in early stage, mid stage, late stage, middle market, and mature transactions.

Investor Profile

TDH Capital has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (33%)
  • Series Unknown (33%)
  • Series A (33%)

Country Focus

  • France (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Communities
  • E-commerce
  • Sharing Economy
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does TDH Capital frequently co-invest with?

Ben Franklin Technology Partners of Southeastern Pennsylvania
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
HD
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Elevation Capital Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Osage Venture Partners
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 1
IC
Europe, Ile-de-France, France, Neuilly-sur-seine
Co-Investments: 2
BioAdvance
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
BD
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by TDH Capital?

YouScribe

Paris, Ile-de-France, France

YouScribe is a community platform for sharing and selling digital publications in France.

CommunitiesE-CommerceSharing Economy
Series UnknownFeb 11, 2022
Amount Raised: $5,675,498
Youdge

Levallois-perret, Ile-de-France, France

Youdge is a digital neo-broker with a aim to make the consumer credit market clear and accessible.

Financial ServicesFinTech
Series AOct 29, 2021
Amount Raised: $5,780,547
Ceptaris Therapeutics

Malvern, Pennsylvania, United States

Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 14, 2006
Amount Raised: $4,500,001